C12N2760/16111 - CPC Classification Index

ClassID:

110808 ⎘

C12N2760/16111 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Orthomyxoviridae Influenzavirus A, i.e. influenza A virus

Sub-classes:

C12N2760/16121 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 158
C12N2760/16122 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 803
C12N2760/16123 » Virus like particles [VLP] 146
C12N2760/16131 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 14
C12N2760/16132 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 22
C12N2760/16133 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 19
C12N2760/16134 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 1,6K
C12N2760/16141 » Use of virus, viral particle or viral elements as a vector 4
C12N2760/16151 » Methods of production or purification of viral material 318
C12N2760/16161 » Methods of inactivation or attenuation 72
C12N2760/16171 » Demonstrated in vivo effect 194
C12N2760/16188 » For redistribution 0

Recent Application in this class:

20250302952

2025-10-02

METHOD OF TREATING INFLUENZA A

20250288660

2025-09-18

SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES

20250257330

2025-08-14

Multipurpose Compositions for Collecting and Transporting Biological Material

20240424081

2024-12-26

SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES

20230181735

2023-06-15

METHOD OF TREATING INFLUENZA A

20230065226

2023-03-02

HOMODIMERIC PROTEIN CONSTRUCTS

20220243180

2022-08-04

Multipurpose Compositions for Collecting and Transporting Biological Material

20210079379

2021-03-18

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

20210079378

2021-03-18

Antigen-binding molecule capable of binding two or more antigen molecules repeatedly

#10

20200397899

2020-12-24

Method of treating influenza A

#11

20200239568

2020-07-30

Homodimeric protein constructs

#12

20200222435

2020-07-16

Mixture of non-digestible oligosaccharides for stimulating the immune system

#13

20200208119

2020-07-02

Avian induced pluripotent stem cells and their use

#14

20200048627

2020-02-13

ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TO TWO OR MORE ANTIGEN MOLECULES REPEATEDLY

#15

20200040040

2020-02-06

Compositions and methods to increase production

#16

20190388534

2019-12-26

Influenza vaccine

#17

20190284559

2019-09-19

E. COLI MEDIATED siRNA SILENCING OF AVIAN INFLUENZA IN CHICKENS

#18

20190083602

2019-03-21

Method for producing RNA molecule compositions

#19

20190076818

2019-03-14

Methods and materials for microorganism capture

#20

20190032023

2019-01-31

Influenza virus replication for vaccine development

#21

20180360819

2018-12-20

ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT

#22

20180282719

2018-10-04

ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TWO OR MORE ANTIGEN MOLECULES REPEATEDLY

#23

20180282718

2018-10-04

Antigen-binding molecule capable of binding two or more antigen molecules repeatedly

#24

20180163277

2018-06-14

Compositions and methods for detection and discrimination of emerging influenza virus subtypes

#25

20180118788

2018-05-03

Influenza virus neutralizing peptidomimetic compounds

#26

20180080043

2018-03-22

EHV insertion site ORF70

#27

20170354720

2017-12-14

Class of therapeutic protein based molecules

#28

20170232022

2017-08-17

Mixture of non-digestible oligosaccharides for stimulating the immune system

#29

20170114103

2017-04-27

Vaccines for use in the prophylaxis and treatment of influenza virus disease

#30

20170067029

2017-03-09

Influenza virus replication for vaccine development

#31

20170044216

2017-02-16

COMPOSITIONS AND METHODS TO INCREASE PRODUCTION

#32

20160348144

2016-12-01

Methods for producing virus particles with simplified glycosylation of surface proteins

#33

20160333319

2016-11-17

Population of isolated chicken cells reprogrammed from somatic cells

#34

20160184407

2016-06-30

Class of therapeutic protein based molecules

#35

20160038591

2016-02-11

Method and apparatus for boosting vaccine efficacy

#36

20160024188

2016-01-28

Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

#37

20160008788

2016-01-14

Methods and materials for microorganism capture

#38

20150126564

2015-05-07

Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand RNA virus infections

#39

20140356388

2014-12-04

Vaccine—screening method

#40

20140328820

2014-11-06

Class of therapeutic protein based molecules

#41

20140255439

2014-09-11

Virus-like particles and process for preparing same

#42

20140065156

2014-03-06

Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

#43

20140011188

2014-01-09

Methods for producing virus particles with simplified glycosylation of surface proteins

#44

20130336963

2013-12-19

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

#45

20130336929

2013-12-19

Methods and cells for identifying RIG-I pathway regulators

#46

20130309248

2013-11-21

Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof

#47

20130303396

2013-11-14

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

#48

20130287832

2013-10-31

Soluble needle arrays for delivery of influenza vaccines

#49

20130251715

2013-09-26

Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof

#50

20130209499

2013-08-15

Vaccines for use in the prophylaxis and treatment of influenza virus disease

#51

20130171140

2013-07-04

Homodimeric protein constructs

#52

20130129770

2013-05-23

Influenza vaccine

#53

20130116267

2013-05-09

Role of PI3K P110 Delta Signaling in Retroviral Infection and Replication

#54

20130067609

2013-03-14

Mammalian Genes Involved in Tularemia and Other Infections

#55

20130011866

2013-01-10

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

#56

20130004502

2013-01-03

Influenza targets

#57

20130004497

2013-01-03

Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof

#58

20130004496

2013-01-03

Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof

#59

20120294874

2012-11-22

Method for Producing T Cell Receptor-Like Monoclonal Antibodies and Uses Thereof

#60

20120276115

2012-11-01

Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

#61

20120246757

2012-09-27

MODULATION OF CELLULAR PROTEIN FUNCTION BY ARTIFICIAL SUMO LIGASES

#62

20120232260

2012-09-13

Amphiphilic nucleotide cochleate compositions and methods of using the same

#63

20120198578

2012-08-02

VIRAL ASSAY

#64

20120184519

2012-07-19

Compositions and Methods for Preventing or Treating Influenza Virus Infection

#65

20120178674

2012-07-12

MIXTURE OF NON-DIGESTIBLE OLIGOSACCHARIDES FOR STIMULATING THE IMMUNE SYSTEM

#66

20120093834

2012-04-19

Neutralizing molecules to viral antigens

#67

20120093823

2012-04-19

Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

#68

20120039905

2012-02-16

The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection

#69

20120039898

2012-02-16

Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof

#70

20120015344

2012-01-19

Methods, compositions, and apparatus for the detection of viral strains

#71

20110311522

2011-12-22

Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof

#72

20110247091

2011-10-06

Transgenic Cells and Chickens Expressing RIG-I

#73

20110209231

2011-08-25

TREATMENT AND PREVENTION OF INFLUENZA

#74

20110206727

2011-08-25

Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof

#75

20110182875

2011-07-28

Class of therapeutic protein based molecules

#76

20110150897

2011-06-23

INFLUENZA TARGETS

#77

20110135655

2011-06-09

Role of PI3K p110 delta Signaling in Retroviral Infection and Replication

#78

20110111406

2011-05-12

ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TO TWO OR MORE ANTIGEN MOLECULES REPEATEDLY

#79

20110077284

2011-03-31

DRY POWDER COMPOSITIONS FOR RNA INFLUENZA THERAPEUTICS

#80

20110033859

2011-02-10

Enhancement of influenza gene expression

#81

20100297126

2010-11-25

Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof

#82

20100266585

2010-10-21

Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof

#83

20100233674

2010-09-16

Cells for detection and production of influenza and parainfluenza viruses

#84

20100178325

2010-07-15

AMPHIPHILIC NUCLEOTIDE COCHLEATE COMPOSITIONS AND METHODS OF USING THE SAME

#85

20100112547

2010-05-06

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF INFLUENZA

#86

20100107264

2010-04-29

Development of influenza A antivirals

#87

20100104533

2010-04-29

EARLY INTERVENTION OF VIRAL INFECTION WITH IMMUNE ACTIVATORS

#88

20100061965

2010-03-11

RESPIRATORY SYNCYTIAL VIRUS RENDERS DENDRITIC CELLS TOLEROGENIC

#89

20100055672

2010-03-04

100% SEQUENCE IDENTITY DETECTION METHODS FOR VARIABLE GENOMES

#90

20100040635

2010-02-18

NEUTRALIZING ANTIBODIES TO INFLUENZA VIRUSES

#91

20090311265

2009-12-17

Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof

#92

20090285819

2009-11-19

METHODS AND COMPOSITIONS FOR TREATING INFLUENZA

#93

20090202983

2009-08-13

Method For Determining The Concentration of Virus Particles/Virus Antigens

#94

20090142327

2009-06-04

Class of therapeutic protein based molecules

#95

20090092620

2009-04-09

Flu virus hemagglutinin specific monoclonal antibodies

#96

20090061417

2009-03-05

INFLUENZA A VIRUS DETECTION METHOD AND KIT THEREFORE

#97

20080279920

2008-11-13

Compositions for treating respiratory viral infections and their use

#98

20070282937

2007-12-06

Methods and systems for data analysis and feature recognition including detection of avian influenza virus

#99

20070253978

2007-11-01

Copy choice recombination and uses thereof

#100

20070197460

2007-08-23

RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION

#101

20070172430

2007-07-26

DRY POWDER COMPOSITIONS FOR RNA INFLUENZA THERAPEUTICS

#102

20070161078

2007-07-12

Methods and compositions for diagnosis and treatment of influenza

#103

20070160982

2007-07-12

Development of influenza A antivirals

#104

20060282921

2006-12-14

Transgenic plant-derived siRNAs for suppression of influenza virus propagation in mammalian cells

#105

20060217341

2006-09-28

DNA vaccine formulations

#106

20050220883

2005-10-06

Microparticles with adsorbed polypeptide-containing molecules

#107

20050112751

2005-05-26

Class of therapeutic protein based molecules

#108

20050015985

2005-01-27

Method and apparatus for forming a refractory lining in a coreless furnace